• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Professional Introduction to 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone (CAS No. 1354018-14-6)

1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone, with the CAS number 1354018-14-6, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of piperidine derivatives, which have garnered considerable attention due to their diverse biological activities and potential therapeutic applications. The structural motif of this molecule, featuring a chiral center at the piperidine ring, makes it a subject of intense interest for synthetic chemists and pharmacologists.

The< strong>S-configuration of the 3-isopropylamino-piperidine moiety is particularly noteworthy, as it influences the stereochemical properties and biological interactions of the compound. Piperidine derivatives are well-known for their role in drug design, often serving as key pharmacophores in small molecule drugs. The presence of an ethanone group at the C1 position of the piperidine ring further enhances its potential as a building block for more complex pharmacological entities.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding affinities and interactions of this compound with various biological targets. Studies have suggested that 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone may exhibit inhibitory effects on certain enzymes and receptors, making it a promising candidate for further investigation in drug discovery programs. The chiral nature of the molecule also opens up possibilities for developing enantiomerically pure drugs, which can significantly improve therapeutic efficacy while minimizing side effects.

In the context of modern drug development, the synthesis of complex molecules like 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone often involves multi-step organic reactions, requiring precise control over reaction conditions and stereochemistry. The use of advanced catalytic systems and asymmetric synthesis techniques has made it possible to produce enantiomerically enriched derivatives with high yields and purity. These advancements are crucial for developing next-generation pharmaceuticals that are more effective and safer.

The pharmacological profile of 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone has been explored in several preclinical studies. Researchers have investigated its potential as an intermediate in the synthesis of novel therapeutic agents targeting neurological disorders, infectious diseases, and metabolic conditions. The compound's ability to interact with specific biological pathways makes it a valuable tool for understanding disease mechanisms and developing targeted treatments.

One of the most exciting aspects of this compound is its versatility in medicinal chemistry. By modifying different functional groups or introducing additional substituents, chemists can generate a library of derivatives with tailored biological activities. This approach allows for rapid screening and optimization of lead compounds, accelerating the drug discovery process. The integration of high-throughput screening technologies with computational modeling has further enhanced the efficiency of this process, enabling researchers to identify promising candidates more quickly.

The synthetic pathways for producing 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone have been optimized to ensure scalability and cost-effectiveness. Modern synthetic strategies often involve green chemistry principles, minimizing waste and reducing environmental impact. These sustainable practices are increasingly important in pharmaceutical manufacturing, as they align with global efforts to promote responsible chemical use.

Future research directions for this compound include exploring its potential in combination therapies and investigating its long-term safety profile. The development of novel drug delivery systems could also enhance the therapeutic applications of 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone by improving bioavailability and targeting specificity. Collaborative efforts between academic institutions, biotechnology companies, and pharmaceutical industries will be essential in translating these findings into clinical applications.

In summary, 1-((S)-3-Isopropylamino-piperidin-1-yl)-ethanone (CAS No. 1354018-14-6) is a versatile and promising compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable asset in drug discovery efforts aimed at addressing various human health challenges. As our understanding of molecular interactions continues to evolve, compounds like this one will play an increasingly important role in developing innovative therapeutic solutions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)